Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unravelling driver genes as potential therapeutic targets in ovarian cancer via integrated bioinformatics approach.

Journal of ovarian research - 23 Apr 2024

Beg Anam, Parveen Rafat, Fouad Hassan, Yahia M E, Hassanein Azza S

Abstract excerpt

Target-driven cancer therapy is a notable advancement in precision oncology that has been accompanied by substantial medical accomplishments. Ovarian cancer is a highly frequent neoplasm in women and exhibits significant genomic and clinical heterogeneity. In a previous publication, we presented an extensive bioinformatics study aimed at identifying specific biomarkers associated with ovarian cancer. The findings...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Computational Biology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Gene Regulatory Networks

Share to Molecular Docking Simulation

Share to Molecular Targeted Therapy

Share to Mutation

Share to Ovarian Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 38654363
DOI: 10.1186/s13048-024-01402-7
PMCID: PMC11036584

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unravelling driver genes as potential therapeutic targets in ovarian cancer via integrated bioinformatics approach.PMID 38654363Read ↗

Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.Semantic proximity Read ↗

Molecular analysis to identify novel potential biomarkers as drug targets in colorectal cancer therapy: an integrated bioinformatics analysisSemantic proximity Read ↗

Identification of prognosis-related hub genes of ovarian cancer through bioinformatics analyses and experimental verificationSemantic proximity Read ↗

In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1.Semantic proximity Read ↗

ITLN1 identified by comprehensive bioinformatic analysis as a hub candidate biological target in human epithelial ovarian cancerSemantic proximity Read ↗

Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silicoSemantic proximity Read ↗

Integrative Bioinformatics Approaches to Map Potential Novel Genes and Pathways Involved in Ovarian CancerSemantic proximity Read ↗

Screening key genes related to ovarian cancer and exploring their possible molecular mechanismsSemantic proximity Read ↗

Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics AnalysisSemantic proximity Read ↗

Bioinformatics and In silico approaches to identify novel biomarkers and key pathways for cancers that are linked to the progression of female infertility: A comprehensive approach for drug discoverySemantic proximity Read ↗

Identification of Potential Therapeutic Targets and Biomarkers for Glioblastomas Through Integrative Analysis of Gene Expression DataSemantic proximity Read ↗

Network-based analysis of candidate oncogenes and pathways in hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.